ILTOO Pharma is revolutionizing the treatment of auto-/neuro-immune diseases. As a brand committed to advancing medical care, ILTOO Pharma offers a range of products and services to address these complex conditions. They are at the forefront of developing Tregs directed therapies, paving the way for innovative treatments for a wide spectrum of auto-/neuroimmune and inflammatory diseases.

Specifically, ILTOO Pharma is dedicated to addressing Amyotrophic Lateral Sclerosis (ALS), which is their top priority indication. By focusing on this debilitating disease, ILTOO Pharma aims to make significant advancements in its treatment and improve the lives of those affected. To achieve their goals, ILTOO Pharma has established strong partnerships with both academic institutions and industrial organizations.

This collaboration allows them to leverage valuable expertise and resources, enabling them to develop groundbreaking therapies for patients. With a commitment to revolutionizing the treatment landscape, ILTOO Pharma is at the forefront of innovation and offers hope to individuals seeking effective solutions for auto-/neuro-immune and inflammatory diseases